|
SYNRG expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.212700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.848400E-04 |
| Normal-vs-Stage2 |
2.139000E-01 |
| Normal-vs-Stage3 |
2.722200E-03 |
| Normal-vs-Stage4 |
1.906300E-02 |
| Stage1-vs-Stage2 |
5.757200E-01 |
| Stage1-vs-Stage3 |
4.094200E-01 |
| Stage1-vs-Stage4 |
3.998200E-01 |
| Stage2-vs-Stage3 |
2.828600E-01 |
| Stage2-vs-Stage4 |
2.784400E-01 |
| Stage3-vs-Stage4 |
7.622400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.198000E-04 |
| Normal-vs-AfricanAmerican |
5.013000E-04 |
| Normal-vs-Asian |
5.852100E-02 |
| Caucasian-vs-AfricanAmerican |
5.597200E-01 |
| Caucasian-vs-Asian |
9.349400E-01 |
| AfricanAmerican-vs-Asian |
8.923600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.2276999999904E-05 |
| Normal-vs-Female |
2.102600E-01 |
| Male-vs-Female |
4.044100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.056900E-03 |
| Normal-vs-Extreme_Weight |
1.91437000000017E-05 |
| Normal-vs-Obese |
8.564600E-03 |
| Normal-vs-Extreme_Obese |
1.559430E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.200200E-01 |
| Normal_Weight-vs-Obese |
5.782000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.332200E-01 |
| Extreme_Weight-vs-Obese |
1.515820E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.329800E-01 |
| Obese-vs-Extreme_Obese |
8.018400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.258200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.880000E-02 |
| Normal-vs-Age(61-80Yrs) |
5.68110000043198E-07 |
| Normal-vs-Age(81-100Yrs) |
3.460700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.000200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.197900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.456080E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.304170E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.438400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.219800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.115720E-03 |
| Normal-VS-Type2 PRCC |
6.777800E-04 |
| Normal-VS-KIRP CIMP |
1.882240E-01 |
| Normal-VS-Unclassified PRCC |
4.095200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.270000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.268400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.618000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.407400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.360580E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.226800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.032670E-04 |
| Normal-vs-N1 |
4.707700E-02 |
| Normal-vs-N2 |
3.888000E-02 |
| N0-vs-N1 |
4.081800E-01 |
| N0-vs-N2 |
9.446200E-01 |
| N1-vs-N2 |
7.580400E-01 |
|
|
